Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Poseida Therapeutics (PSTX) just unveiled an update.
Brent Warner has announced his resignation as President of Gene Therapy at the Company, effective April 1, 2024, in order to take on a new career opportunity elsewhere. This move could signal a shift within the company and is of interest to those tracking leadership changes in the financial markets.
See more insights into PSTX stock on TipRanks’ Stock Analysis page.